These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9207398)

  • 1. Activated protein C resistance can be associated with recurrent fetal loss.
    Brenner B; Mandel H; Lanir N; Younis J; Rothbart H; Ohel G; Blumenfeld Z
    Br J Haematol; 1997 Jun; 97(3):551-4. PubMed ID: 9207398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
    Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
    Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.
    Rai R; Shlebak A; Cohen H; Backos M; Holmes Z; Marriott K; Regan L
    Hum Reprod; 2001 May; 16(5):961-5. PubMed ID: 11331645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
    Younis JS; Ohel G; Brenner B; Haddad S; Lanir N; Ben-Ami M
    BJOG; 2000 Mar; 107(3):415-9. PubMed ID: 10740341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester repeated abortion is not associated with activated protein C resistance.
    Balasch J; Reverter JC; Fábregues F; Tàssies D; Rafel M; Creus M; Vanrell JA
    Hum Reprod; 1997 May; 12(5):1094-7. PubMed ID: 9194672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilia and fetal loss.
    Brenner B; Blumenfeld Z
    Blood Rev; 1997 Jun; 11(2):72-9. PubMed ID: 9242990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion.
    Hashimoto K; Shizusawa Y; Shimoya K; Ohashi K; Shimizu T; Azuma C; Murata Y
    Hum Reprod; 1999 Jul; 14(7):1872-4. PubMed ID: 10402408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.
    Mimuro S; Lahoud R; Beutler L; Trudinger B
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):200-4. PubMed ID: 9653861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor V Leiden mutation is not a common cause of recurrent miscarriage.
    Dizon-Townson DS; Kinney S; Branch DW; Ward K
    J Reprod Immunol; 1997 Oct; 34(3):217-23. PubMed ID: 9350638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss.
    Glueck CJ; Gogenini S; Munjal J; Tracy T; Pranikoff J; Wang P
    Fertil Steril; 2008 Feb; 89(2):410-6. PubMed ID: 17582408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance -- in the absence of factor V Leiden -- and pregnancy.
    Lindqvist PG; Svensson P; Dahlbäck B
    J Thromb Haemost; 2006 Feb; 4(2):361-6. PubMed ID: 16420566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death].
    Santoro R; Iannaccaro P; Sottilotta G
    Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association.
    Sergi C; Al Jishi T; Walker M
    Arch Gynecol Obstet; 2015 Mar; 291(3):671-9. PubMed ID: 25193429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric implications of the factor V leiden mutation: a review.
    Bloomenthal D; Delisle MF; Tessier F; Tsang P
    Am J Perinatol; 2002 Jan; 19(1):37-47. PubMed ID: 11857095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for fetal loss in carriers of the factor V Leiden mutation.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Ann Intern Med; 1999 May; 130(9):736-9. PubMed ID: 10357692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.